Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
I. Panzeri, L. Fagnocchi, S. Apostle…·J. A. Pospisilik
The paper shows that early life epigenetic variation can prime cancer-susceptibility states that persist into adulthood and correlate with poor prognosis in human cancers.
E. Vasileva, M. Warren, T. J. Triche, J. F. Amatruda
This study develops a zebrafish model of Ewing sarcoma and identifies heparan sulfate proteoglycan metabolism as a driver of tumor growth, showing that targeting this pathway reduces tumorigenicity.
M. H. Chasse, B. K. Johnson, E. A. Boguslawski…·P. J. Grohar
This paper shows that targeting the SWI/SNF complex with mithramycin and its analogue EC8042 induces epigenetic reprogramming and durable tumor regression in rhabdoid tumors.
J. W. George, H. Fan, B. K. Johnson…·J. M. Teixeira
This study integrates epigenome, exome, and transcriptome data to identify molecular subtypes and homeotic transformation in uterine fibroids.
H. Bolouri, J. E. Farrar, T. J. Triche…·S. Meshinchi
This study characterizes the molecular landscape of pediatric AML, identifying age-specific mutations and fusion oncoproteins that differ from adult AML.
A. R. Colombo, A. Zubair, D. Thiagarajan…·G. Ramsingh
This study investigates TE suppression in AML and MDS, finding that LSCs and high-risk MDS cases show reduced TE expression, suggesting TE suppression as a mechanism for immune escape.